Legislative Updates

Updates about what is happening on the legislative and regulatory level – news events that affect your digestive health.

The State of Research at NIH & NIDDK

October 02, 2014

In inflation adjusted dollars, National Institutes of Health (NIH) appropriations are approximately at the same level as 15 years ago.

NIDDK is the National Institute for Diabetes and Digestive and Kidney Diseases, one of 27 NIH Institutes and Centers. The NIDDK conducts and supports basic and applied research. Access the website at www.niddk.nih.gov.

Support for H.R. 842 from the Empire State

September 11, 2014

On Wednesday, Representative Peter King cosponsored The Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2013 (H.R. 842). Congressman King represents New York's 2nd congressional district along the South Shore of Long Island.

NIH Funding for 2015 Proposed by Senate Subcommitte

August 13, 2014

Prior to Congress adjourning for their annual summer recess, the Senate Appropriations Committee proposed several measures to be considered for fiscal year (FY) 2015. These included $30.46 billion in funding for the National Institutes of Health (NIH), an increase of $605.67 million over FY 2014. This 2% increase falls short of the $32 billion being requested by the Digestive Health Alliance and the broader health community.

Senate Committee Approves Gulf War Illness Research Funding

July 22, 2014

Gulf War Illness and Functional GI Disorders

On July 17, 2014 the Senate Appropriations Committee included a $47.5 million increase, to $247.5 million, in the Peer-Reviewed Medical Research Program approved in its fiscal year (FY) 2015 Department of Defense (DOD) Appropriations Bill. 

Statement from IFFGD to FDA on Applications for New Drugs

July 18, 2014

Earlier this week, IFFGD President and Co-Founder, Nancy J. Norton, submitted the written statement to the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research in regard to regulatory changes made by FDA for Investigational New Drug Applications (INDs). New guidelines from the FDA, which were published without prior notice or public discussion, require INDs for clinical research studies involving foods. The new guidelines are vague and may also inhibit clinical research in areas that are essential to investigation of functional GI and motility disorders.

Support for H.R. 842 from the Granite State

July 16, 2014

On Tuesday, New Hampshire's Representative Carol Shea-Porter became a cosponsor of The Functional Gastrointestinal and Motility Disorders Research Enhancement Act (H.R. 842). Congresswoman Shea-Porter represents the 1st congressional district in southeastern New Hampshire. 

Another Cosponsor Rejoins The Functional GI & Motility Disorders Research Enhancement Act

July 14, 2014

On July 11, 2014, Representative David Price cosponsored The Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2013 (H.R. 842). Representative Price previously cosponsored The FGIMD Research Enhancement Act of 2011, and we appreciate his continued support of the millions of Americans affected by functional gastrointestinal and motility disorders. 

More Support for H.R. 842 from the Bay State

July 01, 2014

After hearing from constituents during the 2014 Digestive Health Call-In Day and the 2014 DHA Advocacy Day, Representative Richard Neal became a cosponsor of The Functional Gastrointestinal and Motility Disorders Research Enhancement Act (H.R. 842).

Support for H.R. 842 from the Heart of Dixie

May 20, 2014

After persistently hearing from his constituents about the need for increased research, education, and awareness of functional gastrointestinal and motility disorders (FGIMDs), Alabama's Representative Mo Brooks became a cosponsor of The FGIMD Research Enhancement Act of 2013 (H.R. 842). Congressman Brooks represents the 5th congressional district in northern Alabama. 

New Cosponsor for H.R. 842

May 12, 2014

Last week,  Indiana's Representative André Carson became a cosponsor of The Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2013 (H.R. 842). Congressman Carson represents the 7th congressional district in central Indiana.